美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Arch Therapeutics, Inc.

0.1608

0.0000

成交量：- -

成交额：- -

市值：71.47万

市盈率：-0.07

高：0.1608

开：0.1608

低：0.1608

收：0.1608

52周最高：0.8400

52周最低：0.1573

股本：444.44万

流通股本：429.72万

量比：0.03

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-2.3462

每股收益(LYR):-2.2715

净资产收益率：-4014.80%

总资产收益率：-199.27%

市净率：-0.06

市盈率(LYR):-0.07

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Arch Therapeutics, Inc.

交易所：

EXPERT

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.archtherapeutics.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Arch Therapeutics, Inc.于2009年9月16日根据内华达州法律成立。该公司是一家生物技术公司，营销和开发了许多基于创新的AC5自组装技术平台的产品。该公司相信，这些产品可能是止血和屏障应用领域的重要进展，这些应用包括管理手术、创伤、介入治疗或疾病期间产生的伤口、止血（止血）和控制渗漏（密封剂）。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ARTH/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTH\",,,,,undefined,":{"symbol":"ARTH","market":"US","secType":"STK","nameCN":"Arch Therapeutics, Inc.","latestPrice":0.1608,"timestamp":1756497600000,"preClose":0.1608,"halted":0,"volume":0,"delay":15,"floatShares":4297158,"shares":4444400,"eps":-2.346175,"marketStatus":"劳工日休市","change":0,"latestTime":"08-29 16:00:00 EDT 延时","open":0.1608,"high":0.1608,"low":0.1608,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-2.346175,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1756800000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.1608,"volumeRatio":0.028958359685171516},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARTH\",,,,,undefined,":{"symbol":"ARTH","floatShares":4297158,"roa":"-199.27%","roe":"-4014.80%","lyrEps":-2.271494,"volumeRatio":0.028958359685171516,"shares":4444400,"dividePrice":0,"high":0.1608,"amplitude":0,"preClose":0.1608,"low":0.1608,"week52Low":0.1573,"pbRate":"-0.06","psRate":"4.82","week52High":0.84,"institutionHeld":0,"latestPrice":0.1608,"eps":-2.346175,"divideRate":0,"volume":0,"delay":15,"ttmEps":-2.346175,"open":0.1608,"prevYearClose":0.17,"prevWeekClose":0.1608,"prevMonthClose":0.1608,"prevQuarterClose":0.1608,"fiveDayClose":0.1608,"twentyDayClose":0.1608,"sixtyDayClose":0.1608},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-19","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1724040000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-05-09","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-02-20","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1708405200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-08-11","symbol":"ARTH","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1691726400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2023-01-18","symbol":"ARTH","defaultRemindTime":1674052200000,"type":"split","dateTimestamp":1674018000000,"forFactor":200,"toFactor":1,"ratio":200}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARTH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.archtherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0078},{"period":"1month","weight":-0.1321},{"period":"3month","weight":-0.2698},{"period":"6month","weight":-0.3784},{"period":"1year","weight":-0.3867},{"period":"ytd","weight":-0.566}],"description":"Arch Therapeutics, Inc.于2009年9月16日根据内华达州法律成立。该公司是一家生物技术公司，营销和开发了许多基于创新的AC5自组装技术平台的产品。该公司相信，这些产品可能是止血和屏障应用领域的重要进展，这些应用包括管理手术、创伤、介入治疗或疾病期间产生的伤口、止血（止血）和控制渗漏（密封剂）。","exchange":"EXPERT","name":"Arch Therapeutics, Inc.","nameEN":"Arch Therapeutics, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ARTH\",market:\"US\",,,undefined,":null}}